Follow
Patrick Flume
Patrick Flume
Verified email at MUSC.EDU
Title
Cited by
Cited by
Year
Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR
CE Wainwright, JS Elborn, BW Ramsey, G Marigowda, X Huang, M Cipolli, ...
New England Journal of Medicine 373 (3), 220-231, 2015
14942015
Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind …
HGM Heijerman, EF McKone, DG Downey, E Van Braeckel, SM Rowe, ...
The Lancet 394 (10212), 1940-1948, 2019
9802019
Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health
PA Flume, BP O'Sullivan, KA Robinson, CH Goss, PJ Mogayzel Jr, ...
American journal of respiratory and critical care medicine 176 (10), 957-969, 2007
861*2007
Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations
PA Flume, PJ Mogayzel Jr, KA Robinson, CH Goss, RL Rosenblatt, ...
American journal of respiratory and critical care medicine 180 (9), 802-808, 2009
8162009
European cystic fibrosis society standards of care: best practice guidelines
AR Smyth, SC Bell, S Bojcin, M Bryon, A Duff, P Flume, N Kashirskaya, ...
Journal of cystic fibrosis 13, S23-S42, 2014
7432014
ECFS best practice guidelines: the 2018 revision
C Castellani, AJA Duff, SC Bell, HGM Heijerman, A Munck, F Ratjen, ...
Journal of cystic fibrosis 17 (2), 153-178, 2018
7122018
Pulmonary complications after esophagectomy
CE Avendano, PA Flume, GA Silvestri, LB King, CE Reed
The Annals of thoracic surgery 73 (3), 922-926, 2002
4352002
Safety, efficacy and convenience of tobramycin inhalation powder in cystic fibrosis patients: the EAGER trial
MW Konstan, PA Flume, M Kappler, R Chiron, M Higgins, F Brockhaus, ...
Journal of Cystic Fibrosis 10 (1), 54-61, 2011
4202011
Ivacaftor in subjects with cystic fibrosis who are homozygous for the F508del-CFTR mutation
PA Flume, TG Liou, DS Borowitz, H Li, K Yen, CL Ordoñez, DE Geller, ...
Chest 142 (3), 718-724, 2012
4032012
Cystic fibrosis pulmonary guidelines: airway clearance therapies
PA Flume, KA Robinson, BP O'Sullivan, JD Finder, RL Vender, ...
Respiratory care 54 (4), 522-537, 2009
3882009
Treatment of lung infection in patients with cystic fibrosis: current and future strategies
G Döring, P Flume, H Heijerman, JS Elborn, Consensus Study Group
Journal of Cystic Fibrosis 11 (6), 461-479, 2012
3532012
Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research
AT Hill, CS Haworth, S Aliberti, A Barker, F Blasi, W Boersma, ...
European Respiratory Journal 49 (6), 2017
3312017
Cystic fibrosis pulmonary guidelines: pulmonary complications: hemoptysis and pneumothorax
PA Flume, PJ Mogayzel Jr, KA Robinson, RL Rosenblatt, L Quittell, ...
American journal of respiratory and critical care medicine 182 (3), 298-306, 2010
3222010
Efficacy and safety of lumacaftor and ivacaftor in patients aged 6–11 years with cystic fibrosis homozygous for F508del-CFTR: a randomised, placebo-controlled phase 3 trial
F Ratjen, C Hug, G Marigowda, S Tian, X Huang, S Stanojevic, CE Milla, ...
The lancet Respiratory medicine 5 (7), 557-567, 2017
3162017
Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity
PA Flume, JD Chalmers, KN Olivier
The Lancet 392 (10150), 880-890, 2018
2992018
Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Mycobacterium avium Complex (CONVERT). A Prospective, Open …
DE Griffith, G Eagle, R Thomson, TR Aksamit, N Hasegawa, K Morimoto, ...
American journal of respiratory and critical care medicine 198 (12), 1559-1569, 2018
2662018
Massive hemoptysis in cystic fibrosis
PA Flume, JR Yankaskas, M Ebeling, T Hulsey, LL Clark
Chest 128 (2), 729-738, 2005
2372005
Randomized trial of liposomal amikacin for inhalation in nontuberculous mycobacterial lung disease
KN Olivier, DE Griffith, G Eagle, JP McGinnis, L Micioni, K Liu, CL Daley, ...
American journal of respiratory and critical care medicine 195 (6), 814-823, 2017
2302017
Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials
AF Barker, AE O'Donnell, P Flume, PJ Thompson, JD Ruzi, J De Gracia, ...
The lancet Respiratory medicine 2 (9), 738-749, 2014
2242014
Treatment of lung infection in patients with cystic fibrosis: current and future strategies
G Doring, P Flume, H Heijerman, JS Elborn
Journal of Cystic Fibrosis 11 (6), 461-479, 2012
2232012
The system can't perform the operation now. Try again later.
Articles 1–20